18 October 2018
Copenhagen, Denmark

Scientific Programme

Scientific Programme



Thursday, 18 October 2018

08:00-09:00

Registration
  
09:00-10:45 Session I: Food allergy

Chairs: Bernadette Eberlein (Germany), Alexandra Santos (United Kingdom)

09:00-09:25 Integrating BAT and CRD in food allergy, Peter Korosec (Slovenia)
09:25-09:50

BAT results as predictors of clinical reactivity, Bernadette Eberlein (Germany)
09:50-10:45 Oral presentations
09:50-10:05 Correlation of in-vivo oral food challenge with in-vitro basophil activation test in hazelnut allergic patients
10:05-10:20 The early decrease in basophil sensitivity is a biomarker of sustained unresponsiveness in peanut oral immunotherapy
10:20-10:35 Blood stability in BAT Test
  
10:45-11:15

Coffee break
  
11:15-13:00 Session II: Drug hypersensitivity

Chairs: Cristobalina Mayorga (Spain), Anna Nopp Scherman (Sweden)

11:15-11:40 BAT in IgE-mediated and non IgE-mediated hypersensitivity, Cristobalina Mayorga (Spain)
11:40-12:05

Expanding the use of BAT in immediate hypersensitivity, Vito Sabato (Belgium)
12:05-13:00 Oral presentations
11:50-12:05 Basophil Activation test is highly sensitive for the diagnosis of type I gelofusine allergy
12:05-12:20 Drug allergy during pregnancy: A new aspect
12:20-12:35 Monitoring hypersensitivity to a novel IgE immuno-therapy undergoing First-in-Class, First-in-Man clinical trial with the Basophil Activation Test
12:35-12:50 Comparative analysis of basophil gating strategies for the Basophil Activation Test
       
13:00-14:30

Lunch
   
14:30-16:15 Session III: Future Developments

Chairs: Anna Nopp Scherman (Sweden), Edward Knol (The Netherlands)
14:30 – 14:55 Advantages and limitations of BAT, Anna Nopp Scherman (Sweden),
14:55 – 15:20

Automated analysis of BAT, Paul Rozaire (France)
15:20 – 16:15 Oral presentations
15:10-15:25 An automated method for determining quality control. Parameters for basophil activation testing based on flow data
15:25-15:40 Is intracellular histamine a more comprehensive marker for BAT?
15:40-15:55 Feasability evaluation of automating and miniaturizing sasophil activation testing in 96 well plate format
15:55-16:10 Validation experiments on Basophil Activation test using 96-Deep well microtiter plates with desktop flow cytometer detection
  
16:15-16:55 Round table with discussion “External Quality Assurance of the Basophil Activation Test”

16:55-17:00 End of meeting
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel